PPARG and metabolic dysfunction-associated steatotic liver disease: An increasing number of studies have suggested that PPARγ links the NF-κB signaling pathway through being mediated by regulating adipokines via controlled by suppressing TNF-alpha and IL-6, which closely connect to NF-κB and is critical for the treatment of NAFLD (6,7,31).